{"id":298,"date":"2023-04-25T18:59:53","date_gmt":"2023-04-25T18:59:53","guid":{"rendered":"https:\/\/i2u.ca\/?page_id=298"},"modified":"2023-06-01T13:57:25","modified_gmt":"2023-06-01T13:57:25","slug":"our-work-plan","status":"publish","type":"page","link":"https:\/\/i2u.ca\/fr\/our-work-plan\/","title":{"rendered":"Notre plan de travail"},"content":{"rendered":"
\n

Notre plan de travail<\/strong><\/h3>\n<\/div>\n\n\n\n
\n

Afin de mieux comprendre les d\u00e9fis qui emp\u00eachent la mise en \u0153uvre r\u00e9ussie de m\u00e9dicaments r\u00e9volutionnaires au Canada, I2U a commenc\u00e9 ses travaux en 2022 en examinant huit pays de comparaison dans le monde rencontrant bon nombre des m\u00eames obstacles.<\/p>\n\n\n\n

<\/p>\n\n\n\n

I2U a examin\u00e9 huit pays de l'ensemble de base utilis\u00e9 par le Fonds du Commonwealth pour la majeure partie de son analyse comparative : l'Australie; la France; l'Allemagne; les Pays-Bas; la Norv\u00e8ge; la Su\u00e8de; la Suisse; et le Royaume-Uni. Notre objectif \u00e9tait de cartographier la structure du syst\u00e8me de sant\u00e9 et les principaux organismes de chaque juridiction \u2013 et de mieux comprendre leurs approches respectives en mati\u00e8re de soutien \u00e0 la mise en \u0153uvre et de mesure de la valeur.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Notre principale conclusion \u00e9tait qu'aucun des pays que nous avons \u00e9tudi\u00e9s n'avait d'agence ou d'organisation explicitement d\u00e9di\u00e9e \u00e0 l'optimisation de la mise en \u0153uvre de m\u00e9dicaments r\u00e9volutionnaires - ou de technologies de la sant\u00e9 de mani\u00e8re plus g\u00e9n\u00e9rale. Bien que d'autres juridictions aient des programmes et des politiques dignes d'\u00e9mulation, tous les outils que nous d\u00e9velopperons devront \u00eatre cr\u00e9\u00e9s en gardant \u00e0 l'esprit les besoins et les attributs des syst\u00e8mes de sant\u00e9 canadiens.<\/p>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

\n

<\/p>\n\n\n\n

En 2023, I2U a \u00e9labor\u00e9 un plan de travail en quatre phases qui se prolongera jusqu'\u00e0 la fin de l'ann\u00e9e :<\/strong><\/h5>\n<\/div>\n\n\n\n
\n
\n
\n

<\/p>\n\n\n\n

PHASE 1<\/strong><\/h4>\n\n\n\n

Analyse approfondie de l'\u00e9tude de cas<\/h4>\n\n\n\n

De janvier \u00e0 mars<\/em>

Dans la phase 1, notre objectif est de r\u00e9aliser 4 \u00e0 5 \u00e9tudes de cas diverses qui \u00e9claireront la fa\u00e7on dont les syst\u00e8mes de sant\u00e9 canadiens se sont transform\u00e9s (ou non) pour lib\u00e9rer la valeur des innovations r\u00e9volutionnaires. Nous examinerons \u00e9galement les exp\u00e9riences canadiennes par rapport aux pairs mondiaux - pour identifier les cas o\u00f9 d'autres pays ont r\u00e9alis\u00e9 une \u00ab capture de valeur \u00bb meilleure ou plus efficace.<\/p>\n\n\n\n

<\/p>\n<\/div><\/div>\n\n\n\n

\n

<\/p>\n\n\n\n

LA PHASE <\/strong>2<\/h4>\n\n\n\n

\u00c9tude de cas \u00ab Tourn\u00e9e de pr\u00e9sentation \u00bb<\/h4>\n\n\n\n

D'avril \u00e0 juin<\/em>

Au cours de la phase 2, notre objectif est de partager les r\u00e9sultats de nos \u00e9tudes de cas \u2013 et les \u00ab le\u00e7ons apprises \u00bb collectivement avec les dirigeants du syst\u00e8me, les groupes de patients et d'autres intervenants cl\u00e9s.<\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n\n\n\n
\n

<\/p>\n\n\n\n

LA PHASE <\/strong>3<\/h4>\n\n\n\n

D\u00e9veloppement et validation d'une bo\u00eete \u00e0 outils pour les d\u00e9cideurs<\/h4>\n\n\n\n

De juillet \u00e0 septembre<\/em>

Au cours de la phase 3, nous d\u00e9ploierons les connaissances recueillies gr\u00e2ce \u00e0 nos recherches dans un cadre qui aidera les d\u00e9cideurs et les payeurs \u00e0 mieux d\u00e9terminer l'action sp\u00e9cifique requise pour se pr\u00e9parer aux futurs m\u00e9dicaments r\u00e9volutionnaires.\u00a0<\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n\n\n\n
\n

<\/p>\n\n\n\n

LA PHASE <\/strong>4<\/h4>\n\n\n\n

Lancement de la bo\u00eete \u00e0 outils<\/h4>\n\n\n\n

D'octobre \u00e0 d\u00e9cembre<\/em>

Au cours de la phase 4, nous mettrons \u00e0 jour et finaliserons la bo\u00eete \u00e0 outils en fonction des commentaires des responsables du syst\u00e8me et d'autres collaborateurs. Nous \u00ab lancerons \u00bb ensuite publiquement ensemble le cadre et la bo\u00eete \u00e0 outils en tant que pierre angulaire du travail d'I2U.<\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Our Work plan To better understand the challenges preventing the successful implementation of breakthrough medicines in Canada, I2U began its work in 2022 by looking at 8 comparator countries around the world encountering many of the same obstacles. I2U examined 8 countries from the core set used by the Commonwealth Fund for the bulk of […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"{\"coblocks-features-431174850324\":{\"padding\":{},\"margin\":{\"marginBottom\":null,\"marginBottomMobile\":null,\"marginBottomTablet\":null,\"marginLeft\":null,\"marginLeftMobile\":null,\"marginLeftTablet\":null,\"marginRight\":null,\"marginRightMobile\":null,\"marginRightTablet\":null,\"marginTop\":null,\"marginTopMobile\":null,\"marginTopTablet\":null}}}","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","hide_page_title":"","footnotes":""},"class_list":["post-298","page","type-page","status-publish","hentry"],"yoast_head":"\nOur Work Plan - I2U<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/i2u.ca\/fr\/our-work-plan\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our Work Plan - I2U\" \/>\n<meta property=\"og:description\" content=\"Our Work plan To better understand the challenges preventing the successful implementation of breakthrough medicines in Canada, I2U began its work in 2022 by looking at 8 comparator countries around the world encountering many of the same obstacles. I2U examined 8 countries from the core set used by the Commonwealth Fund for the bulk of […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/i2u.ca\/fr\/our-work-plan\/\" \/>\n<meta property=\"og:site_name\" content=\"I2U\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-01T13:57:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/i2u.ca\\\/our-work-plan\\\/\",\"url\":\"https:\\\/\\\/i2u.ca\\\/our-work-plan\\\/\",\"name\":\"Our Work Plan - I2U\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/i2u.ca\\\/#website\"},\"datePublished\":\"2023-04-25T18:59:53+00:00\",\"dateModified\":\"2023-06-01T13:57:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/i2u.ca\\\/our-work-plan\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/i2u.ca\\\/our-work-plan\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/i2u.ca\\\/our-work-plan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/i2u.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Work Plan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/i2u.ca\\\/#website\",\"url\":\"https:\\\/\\\/i2u.ca\\\/\",\"name\":\"I2U\",\"description\":\"Accelerating the Journey from Idea to Utilization\",\"publisher\":{\"@id\":\"https:\\\/\\\/i2u.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/i2u.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/i2u.ca\\\/#organization\",\"name\":\"I2U\",\"url\":\"https:\\\/\\\/i2u.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/i2u.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i2u.ca\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/I2U-Main-Logo.png\",\"contentUrl\":\"https:\\\/\\\/i2u.ca\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/I2U-Main-Logo.png\",\"width\":413,\"height\":275,\"caption\":\"I2U\"},\"image\":{\"@id\":\"https:\\\/\\\/i2u.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our Work Plan - I2U","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/i2u.ca\/fr\/our-work-plan\/","og_locale":"fr_CA","og_type":"article","og_title":"Our Work Plan - I2U","og_description":"Our Work plan To better understand the challenges preventing the successful implementation of breakthrough medicines in Canada, I2U began its work in 2022 by looking at 8 comparator countries around the world encountering many of the same obstacles. I2U examined 8 countries from the core set used by the Commonwealth Fund for the bulk of […]","og_url":"https:\/\/i2u.ca\/fr\/our-work-plan\/","og_site_name":"I2U","article_modified_time":"2023-06-01T13:57:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/i2u.ca\/our-work-plan\/","url":"https:\/\/i2u.ca\/our-work-plan\/","name":"Our Work Plan - I2U","isPartOf":{"@id":"https:\/\/i2u.ca\/#website"},"datePublished":"2023-04-25T18:59:53+00:00","dateModified":"2023-06-01T13:57:25+00:00","breadcrumb":{"@id":"https:\/\/i2u.ca\/our-work-plan\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/i2u.ca\/our-work-plan\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/i2u.ca\/our-work-plan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/i2u.ca\/"},{"@type":"ListItem","position":2,"name":"Our Work Plan"}]},{"@type":"WebSite","@id":"https:\/\/i2u.ca\/#website","url":"https:\/\/i2u.ca\/","name":"I2U","description":"Acc\u00e9l\u00e9rez le parcours de l'id\u00e9e \u00e0 l'utilisation","publisher":{"@id":"https:\/\/i2u.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/i2u.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/i2u.ca\/#organization","name":"I2U","url":"https:\/\/i2u.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/i2u.ca\/#\/schema\/logo\/image\/","url":"https:\/\/i2u.ca\/wp-content\/uploads\/2022\/08\/I2U-Main-Logo.png","contentUrl":"https:\/\/i2u.ca\/wp-content\/uploads\/2022\/08\/I2U-Main-Logo.png","width":413,"height":275,"caption":"I2U"},"image":{"@id":"https:\/\/i2u.ca\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/pages\/298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/comments?post=298"}],"version-history":[{"count":9,"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/pages\/298\/revisions"}],"predecessor-version":[{"id":420,"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/pages\/298\/revisions\/420"}],"wp:attachment":[{"href":"https:\/\/i2u.ca\/fr\/wp-json\/wp\/v2\/media?parent=298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}